[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355769-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355769-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","analysis-of-intratumoural-bacteria-opportunities-and-challenges-for-cancer-therapy","Analysis of intratumoural bacteria: Opportunities and challenges for cancer therapy","","Intratumoural bacteria influence tumour behaviour through antagonistic effects on immune modulation and cancer-specific prognostic outcomes. Their heterogeneity reflects multiple drivers, including tumour molecular subtypes, spatial niches, disease stage, genetic alterations, and mixed clonal populations, alongside differences in angiogenesis, oxygen availability, microbial origins, and vesicle-related uptake processes such as endocytosis and micropinocytosis. This review surveys intratumoural bacterial diversity across 25 cancer types and consolidates mechanisms linking bacterial roles to tumour progression and anticancer responses. It also summarizes engineered-bacteria interventions, including strategies used in clinical trials.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/analysis-of-intratumoural-bacteria-opportunities-and-challenges-for-cancer-therapy/355769/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/analysis-of-intratumoural-bacteria-opportunities-and-challenges-for-cancer-therapy/355769.png","ImageObject",300,407,{"name":42,"@type":43},"Adam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What roles do intratumoural bacteria play in tumours?","Question",{"text":63,"@type":64},"Intratumoural bacteria can promote or inhibit tumour growth, while shaping therapeutic response. Their effects depend on context within the tumour microenvironment.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why are the effects of intratumoural bacteria considered heterogeneous?",{"text":68,"@type":64},"Heterogeneity arises from tumour molecular subtypes, spatial location, cancer stage, genetic alterations, multiple subclones, and variations in angiogenesis, oxygen levels, microbial sources, and uptake processes.",{"name":70,"@type":61,"acceptedAnswer":71},"How can intratumoural bacteria be used in cancer therapy?",{"text":72,"@type":64},"They may serve as prognostic biomarkers and inspire microbial-driven therapeutic strategies. The review also summarizes engineered bacteria interventions, including approaches applied in clinical trials.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355769,1790198667,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404737137,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Acta Pharmaceutica Sinica B 2026;16(5):2877—2902  \nChinese Pharmaceutical Association Institute of Materia Medica, Chinese Academy of Medical Sciences  \nActa Pharmaceutica Sinica B  \n[www. else vier. com/locate/apsb](www. else vier. com/locate/apsb)[ ](www. else vier. com/locate/apsb)[www. sciencedirect . com](www. sciencedirect . com)  \nREVIEW  \nAnalysis of intratumoural bacteria:  \nOpportunities and challenges for cancer therapy  \nXiaowen Jianga,b, Chunyan Zhangc, Simeng Caoa, Yeheng Penga, Mingyi Zhaob, Xuyao Zhanga,d,*, Yuan Gaoa,d,*  \naSchool of Pharmaceutical Science, Fudan University, Shanghai 201203, China  \nbSchool of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China cDepartment of Stomatology, Qingdao Municipal Hospital, Qingdao 266011, China  \ndState Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai 201206, China  \nReceived 7 July 2025; received in revised form 4 September 2025; accepted 30 September 2025  \nKEY WORDS  \nIntratumoural bacteria; Prognostic biomarkers; Engineered bacteria; Microbial sequencing; Drug vector;  \nImmunotherapy;  \nRelative abundance; Antibiotics  \nAbstract Intratumoural bacteria have been shown to play conflicting roles within tumours, especially in the modulation of immune responses. Moreover, bacteria have been linked to a variety of cancer types and have different prognostic values depending on the cancer. This heterogeneity is not only shaped by tumour molecular subtypes, spatial location, cancer progression stage, genetic alterations, and the presence of multiple subclones, but is also influenced by variations in angiogenesis, oxygen levels, microbial sources, endocytosis and micropinocytosis. In this review, we describe the diversity of intratumoural bacteria across 25 cancer types covering an extensive spectrum of analyzed intratumoural bacteria. Furthermore, the dual roles and mechanisms of their involvement in tumour progression and anticancer activity are summarized. Additionally, interventions and applications of engineered bacteria in cancer therapy, especially strategies used in clinical trials, are illustrated. This work describes the roles of intratumoural bacteria and their metabolic byproducts as regulators within the tumour microenvironment and highlights the potential translation of bacteria for cancer therapy.  \nª 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)) .  \n*Corresponding authors.  \nE-mail addresses: [yuan_gao@fudan.edu.cn](yuan_gao@fudan.edu.cn) (Yuan Gao), [xuyaozhang@fudan.edu.cn](xuyaozhang@fudan.edu.cn) (Xuyao Zhang) .  \nPeer review under the responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.  \n[https://doi.org/10.1016/j.apsb.2026.03.022](https://doi.org/10.1016/j.apsb.2026.03.022)  \n2211-3835 ª 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)) .  \n1. Introduction  \nAs critical modulators, intratumoural bacteria have received widespread attention because of their function in cancer initiation, progression, and therapeutic response based on their ability to alter the balance of cell proliferation and apoptosis, and their immunological as well as metabolic interplay within the tumour microenvironment (TME) 1—4.  \nRecent advancements in high-resolution sequencing and spatially analytical metagenomics have facilitated the detection of microorganisms at tumour sites by measuring ","cbCaivvxP7bTyK7J","https://ap.wps.com/l/cbCaivvxP7bTyK7J","pdf",7593836,26,"English","# 1. Introduction\n## 1.1 Intratumoural bacteria as modulators of cancer and therapy response\n## 1.2 Advances in sequencing and spatial metagenomics","[{\"question\":\"What roles do intratumoural bacteria play in tumours?\",\"answer\":\"Intratumoural bacteria can promote or inhibit tumour growth, while shaping therapeutic response. Their effects depend on context within the tumour microenvironment.\"},{\"question\":\"Why are the effects of intratumoural bacteria considered heterogeneous?\",\"answer\":\"Heterogeneity arises from tumour molecular subtypes, spatial location, cancer stage, genetic alterations, multiple subclones, and variations in angiogenesis, oxygen levels, microbial sources, and uptake processes.\"},{\"question\":\"How can intratumoural bacteria be used in cancer therapy?\",\"answer\":\"They may serve as prognostic biomarkers and inspire microbial-driven therapeutic strategies. The review also summarizes engineered bacteria interventions, including approaches applied in clinical trials.\"}]","Analysis of intratumoural bacteria: Opportunities and challenges for cancer therapy | PDF",1790120870,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/543c251e8e4275fda58c7d2fb670651d.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2221bd50b55467ecd719048dcc63548.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4100eb5875f55df0a7e7cb97ffb0f94.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b98c9e2ca06a63ca6c4597a7c77c936.webp",980,734]